On the role of antibody affinity and avidity in the IgE ‐mediated allergic response
Allergy · 2025-01 · 80 (1) · 37-46
DOI: 10.1111/all.16248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 27.08.2024. Verfasst von Martin F Bachmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, University Hospital of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Immunoglobulin E, Antibody Affinity, Hypersensitivity, Basophils. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Type I hypersensitivity, also known as classical allergy, is mediated via allergen‐specific IgE antibodies bound to type I FcR (FcεRI) on the surface of mast cells and basophils upon cross‐linking by allergens. This IgE‐mediated cellular activation may be blocked by allergen‐specific IgG through multiple mechanisms, including direct neutralization of the allergen or engagement of the inhibitory receptor FcγRIIb which blocks IgE signal transduction. In addition, co‐engagement of FcεRI and FcγRIIb by IgE‐IgG‐allergen immune complexes causes down regulation of receptor‐bound IgE, resulting in desensitization of the cells. Both, activation of FcεRI by allergen‐specific IgE and engagement of FcγRIIb by allergen‐specific IgG are driven by allergen‐binding. Here we delineate the distinct roles of antibody affinity versus avidity in driving these processes and discuss the role of IgG subclasses in inhibiting basophil and mast cell activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, University Hospital of Bern, Bern, Switzerland.
- Department for Biomedical Research Bern (DBMR), University of Bern, Bern, Switzerland.
- Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, UK.
- Allergy Therapeutics, Worthing, UK.
- Bencard Allergie GmbH, Munich, Germany.
- SeromYx Systems, Cambridge, Massachusetts, USA.
ORCID-Profile: Martin F Bachmann, Pascal S Krenger, Mona O Mohsen, Matthias F Kramer, Sviatlana Starchenka, Monique Vogel, Matthew D Heath
Zitieren
APA
Bachmann, M. F., Krenger, P. S., Mohsen, M. O., Kramer, M. F., Starchenka, S., Whitehead, P., Vogel, M., & Heath, M. D. (2025). On the role of antibody affinity and avidity in the IgE ‐mediated allergic response. Allergy, 80(1), 37-46. https://doi.org/10.1111/all.16248
Vancouver
Bachmann MF, Krenger PS, Mohsen MO, Kramer MF, Starchenka S, Whitehead P, et al. On the role of antibody affinity and avidity in the IgE ‐mediated allergic response. Allergy. 2025;80(1):37-46. doi:10.1111/all.16248
BibTeX
@article{Bachmann2025,
author = {Bachmann, Martin F and Krenger, Pascal S and Mohsen, Mona O and Kramer, Matthias F and Starchenka, Sviatlana and Whitehead, Piers and Vogel, Monique and Heath, Matthew D},
title = {On the role of antibody affinity and avidity in the IgE ‐mediated allergic response},
journal = {Allergy},
year = {2025},
volume = {80},
number = {1},
pages = {37--46},
doi = {10.1111/all.16248}
}
EUVIMED